Potential use of endemic human coronaviruses to stimulate immunity against pathogenic SARS-CoV-2 and its variants
暂无分享,去创建一个
[1] B. Agrawal,et al. Heterologous immunity induced by 1st generation COVID-19 vaccines and its role in developing a pan-coronavirus vaccine , 2022, Frontiers in Immunology.
[2] Frederick Albert Matsen IV,et al. Distinct Antibody Responses to Endemic Coronaviruses Pre- and Post-SARS-CoV-2 Infection in Kenyan Infants and Mothers , 2022, Viruses.
[3] Frederick Albert Matsen IV,et al. Distinct antibody responses to endemic coronaviruses pre- and post-SARS-CoV-2 infection in Kenyan infants and mothers , 2022, bioRxiv.
[4] R. Doty. Olfactory dysfunction in COVID-19: pathology and long-term implications for brain health , 2022, Trends in Molecular Medicine.
[5] M. Zand,et al. Broad Cross-Reactive IgA and IgG against Human Coronaviruses in Milk Induced by COVID-19 Vaccination and Infection , 2022, Vaccines.
[6] G. Kuan,et al. SARS-CoV-2 and endemic coronaviruses: Comparing symptom presentation and severity of symptomatic illness among Nicaraguan children , 2022, PLOS global public health.
[7] E. Karlsson,et al. Rapid Generation of In-House Serological Assays Is Comparable to Commercial Kits Critical for Early Response to Pandemics: A Case With SARS-CoV-2 , 2022, Frontiers in Medicine.
[8] P. Dönnes,et al. Long‐term SARS‐CoV‐2‐specific and cross‐reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology , 2022, Immunity, inflammation and disease.
[9] K. Yuen,et al. A nasal omicron vaccine booster elicits potent neutralizing antibody response against emerging SARS-CoV-2 variants , 2022, Emerging microbes & infections.
[10] R. Tiwari,et al. COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges , 2022, Human vaccines & immunotherapeutics.
[11] A. Sette,et al. Immunological memory to Common Cold Coronaviruses assessed longitudinally over a three-year period , 2022, bioRxiv.
[12] M. McConnell,et al. Cross-Recognition of SARS-CoV-2 B-Cell Epitopes with Other Betacoronavirus Nucleoproteins , 2022, International journal of molecular sciences.
[13] Chloe H. Lee,et al. HLA‐dependent variation in SARS‐CoV‐2 CD8 + T cell cross‐reactivity with human coronaviruses , 2022, Immunology.
[14] D. Bailey,et al. Known Cellular and Receptor Interactions of Animal and Human Coronaviruses: A Review , 2022, Viruses.
[15] R. Finberg,et al. Broadly recognized, cross-reactive SARS-CoV-2 CD4 T cell epitopes are highly conserved across human coronaviruses and presented by common HLA alleles , 2022, bioRxiv.
[16] N. Curtis,et al. Why Does the Severity of COVID-19 Differ With Age? , 2021, The Pediatric infectious disease journal.
[17] Scott A. Brown,et al. Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response , 2021, Cell Host & Microbe.
[18] Carly A. Bobak,et al. Boosting of Cross-Reactive Antibodies to Endemic Coronaviruses by SARS-CoV-2 Infection but not Vaccination with Stabilized Spike , 2021, medRxiv.
[19] I. Rea,et al. Triple jeopardy in ageing: COVID-19, co-morbidities and inflamm-ageing , 2021, Ageing Research Reviews.
[20] A. Okoh,et al. An Overview of the Pathogenesis, Transmission, Diagnosis, and Management of Endemic Human Coronaviruses: A Reflection on the Past and Present Episodes and Possible Future Outbreaks , 2021, Pathogens.
[21] S. P. Dumre,et al. Efficacy of face masks against respiratory infectious diseases: a systematic review and network analysis of randomized-controlled trials , 2021, Journal of breath research.
[22] S. Soltani,et al. An overview on the seven pathogenic human coronaviruses , 2021, Reviews in medical virology.
[23] J. Hurwitz,et al. Cross-Reactive Immune Responses toward the Common Cold Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Mini-Review and a Murine Study , 2021, Microorganisms.
[24] M. Zand,et al. Antibody Mediated Immunity to SARS-CoV-2 and Human Coronaviruses: Multiplex Beads Assay and Volumetric Absorptive Microsampling to Generate Immune Repertoire Cartography , 2021, Frontiers in Immunology.
[25] Chloe H. Lee,et al. HLA-dependent variation in SARS-CoV-2 CD8+ T cell cross-reactivity with human coronaviruses , 2021, bioRxiv.
[26] N. Temperton,et al. Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post–COVID-19 Convalescent Samples , 2021, The Journal of infectious diseases.
[27] D. Scott,et al. Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers , 2021, BMC Infectious Diseases.
[28] S. Madhi,et al. T-cell responses to SARS-CoV-2 in unexposed South African women , 2021, Gates open research.
[29] K. Überla,et al. SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses , 2021, Frontiers in Immunology.
[30] M. Dalakas,et al. Anti-SARS-CoV-2 Antibodies Within IVIg Preparations: Cross-Reactivities With Seasonal Coronaviruses, Natural Autoimmunity, and Therapeutic Implications , 2021, Frontiers in Immunology.
[31] G. Ogg,et al. Identification of Novel Candidate CD8+ T Cell Epitopes of the SARS-CoV2 with Homology to Other Seasonal Coronaviruses , 2021, Viruses.
[32] E. Tejera,et al. Pre-existing T-cell immunity to SARS-CoV-2 in unexposed healthy controls in Ecuador, as detected with a COVID-19 Interferon-Gamma Release Assay , 2021, International Journal of Infectious Diseases.
[33] E. Shin,et al. SARS-CoV-2-Specific T Cell Responses in Patients with COVID-19 and Unexposed Individuals , 2021, Immune network.
[34] A. Seppo,et al. Human Milk Antibodies against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with a Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers , 2021, International journal of molecular sciences.
[35] M. Saier,et al. The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis , 2021, International journal of molecular sciences.
[36] J. Kaushal,et al. Asia's largest urban slum-Dharavi: A global model for management of COVID-19 , 2021, Cities.
[37] Gregory L. Watson,et al. An evidence review of face masks against COVID-19 , 2021, Proceedings of the National Academy of Sciences.
[38] S. Agnandji,et al. Evidence and implications of pre‐existing humoral cross‐reactive immunity to SARS‐CoV‐2 , 2020, Immunity, inflammation and disease.
[39] B. Bosch,et al. Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63 , 2020, Scientific Reports.
[40] David S. Goodsell,et al. RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences , 2020, Nucleic Acids Res..
[41] Sagar,et al. Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells , 2020, Nature Medicine.
[42] N. Cimolai. Complicating Infections Associated with Common Endemic Human Respiratory Coronaviruses. , 2020, Health security.
[43] J. West,et al. High prevalence of pre-existing serological cross-reactivity against SARS-CoV-2 in sub-Sahara Africa , 2020, International Journal of Infectious Diseases.
[44] G. Whittaker,et al. Molecular diversity of coronavirus host cell entry receptors , 2020, FEMS microbiology reviews.
[45] V. Thiel,et al. Coronavirus biology and replication: implications for SARS-CoV-2 , 2020, Nature Reviews Microbiology.
[46] H. Rammensee,et al. SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition , 2020, Nature immunology.
[47] N. Miller,et al. Recent endemic coronavirus infection is associated with less severe COVID-19. , 2020, The Journal of clinical investigation.
[48] N. Hacohen,et al. Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity , 2020, Science.
[49] O. Laeyendecker,et al. Healthy donor T-cell responses to common cold coronaviruses and SARS-CoV-2. , 2020, The Journal of clinical investigation.
[50] P. Doshi. Covid-19: Do many people have pre-existing immunity? , 2020, BMJ.
[51] O. Bagasra,et al. Infectivity of Human Olfactory Neurons to SARS-CoV-2: A Link to Anosmia , 2020, Oman medical journal.
[52] B. Murphy,et al. Coronavirus Infections in Companion Animals: Virology, Epidemiology, Clinical and Pathologic Features , 2020, Viruses.
[53] S. Mallal,et al. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans , 2020, Science.
[54] I. Artika,et al. Molecular biology of coronaviruses: current knowledge , 2020, Heliyon.
[55] U. Reimer,et al. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19 , 2020, Nature.
[56] Francisco A. Chaves,et al. S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit , 2020, mBio.
[57] Martin Linster,et al. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls , 2020, Nature.
[58] E. Hartenian,et al. The molecular virology of coronaviruses , 2020, The Journal of Biological Chemistry.
[59] A. Sette,et al. Pre-existing immunity to SARS-CoV-2: the knowns and unknowns , 2020, Nature Reviews Immunology.
[60] Gheyath K Nasrallah,et al. Distinct antibody repertoires against endemic human coronaviruses in children and adults , 2020, bioRxiv.
[61] Md. Imtaiyaz Hassan,et al. Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach , 2020, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.
[62] C. Poh,et al. Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients , 2020, Nature Communications.
[63] Xiaosheng Wang,et al. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues , 2020, Infectious Diseases of Poverty.
[64] C. Chiu,et al. What’s New With the Old Coronaviruses? , 2020, Journal of the Pediatric Infectious Diseases Society.
[65] A. Lorusso,et al. Novel human coronavirus (SARS-CoV-2): A lesson from animal coronaviruses , 2020, Veterinary Microbiology.
[66] Wayne T. Nicholson,et al. Deployment of convalescent plasma for the prevention and treatment of COVID-19. , 2020, The Journal of clinical investigation.
[67] P. Felgner,et al. Analysis of Serologic Cross-Reactivity Between Common Human Coronaviruses and SARS-CoV-2 Using Coronavirus Antigen Microarray , 2020, bioRxiv.
[68] Qi Jin,et al. Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19) , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[69] A. Walls,et al. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein , 2020, Cell.
[70] A. Walls,et al. Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion , 2019, Cell.
[71] Jie Cui,et al. Origin and evolution of pathogenic coronaviruses , 2018, Nature Reviews Microbiology.
[72] Nitin A. Pagedar,et al. Nasal priming by a murine coronavirus provides protective immunity against lethal heterologous virus pneumonia. , 2018, JCI insight.
[73] F. Rey,et al. Common Features of Enveloped Viruses and Implications for Immunogen Design for Next-Generation Vaccines , 2018, Cell.
[74] Z. Rao,et al. Structural characterization of the HCoV-229E fusion core , 2018, Biochemical and Biophysical Research Communications.
[75] V. Corman,et al. Hosts and Sources of Endemic Human Coronaviruses , 2018, Advances in Virus Research.
[76] S. Perlman,et al. Coronaviruses: An Overview of Their Replication and Pathogenesis , 2015, Methods in molecular biology.
[77] T. Kuijpers,et al. The dominance of human coronavirus OC43 and NL63 infections in infants , 2011, Journal of Clinical Virology.
[78] P. Simmonds,et al. Epidemiology and Clinical Presentations of the Four Human Coronaviruses 229E, HKU1, NL63, and OC43 Detected over 3 Years Using a Novel Multiplex Real-Time PCR Method , 2010 .
[79] K. Pyrć,et al. Human Coronavirus NL63 and 229E Seroconversion in Children , 2008, Journal of Clinical Microbiology.
[80] Guoping Zhao,et al. Molecular Evolution of the SARS Coronavirus During the Course of the SARS Epidemic in China , 2004, Science.
[81] P. Talbot,et al. Coronavirus-related nosocomial viral respiratory infections in a neonatal and paediatric intensive care unit: a prospective study , 2002, Journal of Hospital Infection.